|
gptkbp:instanceOf
|
gptkb:Corticosteroid
|
|
gptkbp:approvedBy
|
1955
|
|
gptkbp:ATCCode
|
gptkb:H02AB07
|
|
gptkbp:CASNumber
|
53-03-2
|
|
gptkbp:contraindication
|
systemic fungal infections
|
|
gptkbp:discoveredBy
|
gptkb:Arthur_Nobile
|
|
gptkbp:discoveredIn
|
1955
|
|
gptkbp:eliminationHalfLife
|
2-3 hours
|
|
gptkbp:hasGenericVersion
|
true
|
|
gptkbp:hasMolecularFormula
|
C21H26O5
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
prednisone
|
|
gptkbp:isApprovedDrug
|
true
|
|
gptkbp:isNotAnalgesic
|
true
|
|
gptkbp:isNotAntibiotic
|
true
|
|
gptkbp:isNotControlledSubstance
|
true
|
|
gptkbp:isNotNSAID
|
true
|
|
gptkbp:isOnWorldHealthOrganizationEssentialMedicinesList
|
true
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:MeSH_ID
|
gptkb:D011238
|
|
gptkbp:metabolism
|
gptkb:prednisolone
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
gptkb:DB00635
5755
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
gptkb:cataracts
gptkb:bone
high blood pressure
glaucoma
mood changes
weight gain
insomnia
hyperglycemia
increased infection risk
|
|
gptkbp:UNII
|
VB0R961HZT
|
|
gptkbp:usedFor
|
gptkb:Crohn's_disease
asthma
autoimmune disorders
multiple sclerosis
ulcerative colitis
inflammatory diseases
lupus
rheumatoid arthritis
allergic reactions
adrenal insufficiency
organ transplant rejection prevention
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:prednisolone
gptkb:Corticosteroid
|
|
gptkbp:bfsLayer
|
6
|